非糖尿病孕妇HbA1c≤6%与种族对出生体重及新生儿低血糖的影响
该回顾性病历复习纳入4769名≥34周出生的婴儿,评估无糖尿病孕妇妊娠期HbA1c≤6%及母亲种族对新生儿低血糖和出生体重的影响。结果显示妊娠HbA1c与出生体重直接相关,HbA1c、种族、早产、剖宫产和出生体重可预测低血糖,白人种族中相关性更明显。
要点
- 妊娠HbA1c在4.8%–6.0%范围内与出生体重直接相关,白人和非裔美国人均如此。
- HbA1c每升高0.1%增加新生儿低血糖 odds:非裔美国人6.4%,白人12.0%。
- 妊娠期使用β受体阻滞剂、糖尿病或两者兼有均升高新生儿低血糖 odds。
核心结论
- 妊娠HbA1c在4.8%–6.0%(孕期通常认为可接受)范围内仍影响新生儿低血糖和出生体重,白人种族中更明显。
- 妊娠晚期HbA1c>5.2%是新生儿低血糖的潜在危险因素,尤其早产儿。
- 需前瞻性研究验证上述发现并确定孕期「最佳」HbA1c水平。
研究设计与样本
- 预设分组:无妊娠合并症母亲组(N)、产前暴露β受体阻滞剂组(B)、糖尿病组(D)、两者兼有组(DB)。
主要发现
- N组中白人(n=1756;β=2.6,P<.001)和非裔美国人(n=1872;β=2.2,P=.002)妊娠HbA1c与出生体重均呈直接关系。
- HbA1c(aOR 1.8;95%CI 1.3–2.5)、母亲种族、早产、剖宫产和出生体重可预测低血糖。
- HbA1c在4.8–6之间每升高0.1%,低血糖 odds 在非裔美国人增加6.4%(β 0.62,SE 0.22,P=.01),白人增加12.0%(β 1.13,SE 0.23,P<.001)。
- 与N组相比,新生儿低血糖 odds 在B组为1.7倍、D组为2.1倍、DB组为3.1倍。
关键数值与推荐
- 妊娠HbA1c 4.8%–6.0%与出生体重直接相关,白人β=2.6(P<.001),非裔美国人β=2.2(P=.002)。
- HbA1c预测低血糖的aOR为1.8(95%CI 1.3–2.5)。
- HbA1c 4.8–6之间每升高0.1%,低血糖 odds 增加:非裔美国人6.4%(P=.01),白人12.0%(P<.001)。
- 低血糖 odds 相对N组:B组1.7倍、D组2.1倍、DB组3.1倍。
- 妊娠晚期HbA1c>5.2%为新生儿低血糖潜在危险因素,尤其早产儿。
临床怎么用
- 对无糖尿病孕妇也应关注妊娠HbA1c水平,4.8%–6.0%并非对新生儿结局无影响。
- 妊娠晚期HbA1c>5.2%的早产儿可考虑加强新生儿低血糖监测。
- 母亲使用β受体阻滞剂或合并糖尿病时,新生儿低血糖风险进一步升高,应提高警惕。
- 母亲种族可纳入新生儿低血糖风险评估的参考因素。
局限性
- 为回顾性病历复习,结论需前瞻性研究验证。
- 原文未报告前瞻性验证结果及孕期「最佳」HbA1c水平的具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether pregnancy glycated hemoglobin (HbA1c) levels of ≤6% and maternal race impacts neonatal hypoglycemia and birthweight, and whether diabetes and beta blocker use during pregnancy additively impacts neonatal outcomes. STUDY DESIGN: Retrospective chart review of 4769 infants born at ≥34 weeks; 21 482 glucose measurements were assessed. Predefined groups were infants born to mothers without documented pregnancy conditions (group N), prenatal exposure of beta blockers (group B), diabetes (group D), or both (group DB). RESULTS: In group N, both in Caucasian (Caucasian, n = 1756; β = 2.6, P < .001) and African American (n = 1872; β = 2.2, P = .002) race, there was a direct relationship between pregnancy HbA1c levels and birthweight. HbA1c (aOR 1.8; 95% CI [1.3-2.5]) levels, maternal race, prematurity, cesarean delivery, and birth weight predicted hypoglycemia. Each 0.1% increase in HbA1c levels between 4.8 and 6 increased the odds of neonatal hypoglycemia by 6.4% in African American (β 0.62, SE 0.22, P = .01) and by 12.0% in Caucasian (β 1.13, SE 0.23 P < .001) population. The odds of neonatal hypoglycemia were 1.7 (group B), 2.1 (group D), and 3.1 (group DB) times higher compared with group N. CONCLUSIONS: Pregnancy HbA1c levels between 4.8% and 6.0% considered acceptable during pregnancy impacts neonatal hypoglycemia and birthweight especially in Caucasian race. A third trimester HbA1c >5.2 is a potential risk factor for neonatal hypoglycemia, especially in preterm infants. Although we report new findings on the relationship between maternal HbA1c levels and neonatal outcomes, a prospective study is required to validate our findings and determine "optimal" HbA1C levels during pregnancy.
引用
- Kumar N, Kumar P, Harris N, et al. Impact of Maternal HbA1c Levels ≤6% and Race in Nondiabetic Pregnancies on Birthweight and Early Neonatal Hypoglycemia. J Pediatr. 2020. PMID: 32800816. doi:10.1016/j.jpeds.2020.08.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。